1. Adelman, M. J., & Baldia, S. (1996). Prospects and limits of the patent provision in the TRIPS agreement: The case of India. Vanderbilt Journal of Transnational Law, 29, 507.
2. Anand, G. (2016). ‘True scale’ of India’s tuberculosis problem: 2.8 million new cases, The New York Times.
https://www.nytimes.com/2016/10/14/world/asia/true-scale-of-indias-tuberculosis-problem-2-8-million-new-cases.html
. Accessed June 28, 2017.
3. Anonymous. (2005). Drug prices: Requiem for DPCO? Economic and Political Weekly, 40(33), 3620.
4. Arrow, K. J. (1963). Uncertainty and the welfare economics of medical care. The American Economic Review, American Economic Association, 53(5), 941–973.
http://www.jstor.org/stable/1812044
. Accessed February 2, 2013.
5. AVERT. (2015). HIV and AIDS in India.
https://www.avert.org/professionals/hiv-around-world/asia-pacific/india
. Accessed June 28, 2017.